Laboratory diagnosis of metabolic myopathies.
The metabolic myopathies are a heterogeneous group of disorders inherited by a variety of modes that include gene defects in both the nuclear and mitochondrial genomes. Many factors impact on the expression of the pathogenic mutations that cause these disorders including genetic background, environmental factors, and coexisting disorders. Molecular technology has greatly improved the ability to make definitive diagnoses in many of the metabolic myopathies in the last decade and particularly has demonstrated that the wide diversity in the severity of mutations contributes to understanding genotype-phenotype correlations. In some cases, molecular testing obviates the necessity to perform an invasive muscle biopsy. However, it is also clear that the diagnostic yield from molecular testing is incomplete and particularly low among the mitochondrial myopathies as a group, ranging from approximately 6% to 19% in well-classified high-risk groups. Therefore, it is often essential to combine clinical, biochemical, histopathologic, and molecular data for each patient in order to arrive at a definitive diagnosis. The approach to the laboratory diagnosis of metabolic myopathies is described emphasizing both noninvasive and invasive testing, highlighting the molecular methodologies with the benefits and disadvantages of each technology, and documenting how to determine whether patients have coexisting disorders.
Vladutiu
Georgirene D
GD
Departments of Pediatrics, Neurology, and Pathology, Division of Genetics, School of Medicine & Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.|Department of Pediatrics, The Children's Hospital of Buffalo, 936 Delaware Avenue, Buffalo, New York, 14209, USA.
D019411:Clinical Laboratory Techniques; D006801:Humans; D008659:Metabolic Diseases / Q000175:diagnosis* / Q000235:genetics; D009135:Muscular Diseases / Q000175:diagnosis* / Q000235:genetics; D009154:Mutation